FDA Approves Johnson & Johnson’s Pulsed Field Ablation Platform for AFib
The single-device solution combines pulsed field ablation therapy and advanced mapping for treating drug-refractory paroxysmal atrial fibrillation.
The single-device solution combines pulsed field ablation therapy and advanced mapping for treating drug-refractory paroxysmal atrial fibrillation.